Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified High Dose Melphalan and Auto-SCT for MM and AL Amyloidosis
NCT00064337Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Jan 2004
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melphalan in multiple myeloma (MM), amyloid light chain amyloidosis, light chain deposition disease (LCDD), sponsored by SWOG Cancer Research Network. Started Jan 2004; status: completed.
02
Drugs
melphalan
03
Conditions
multiple myeloma (MM)amyloid light chain amyloidosislight chain deposition disease (LCDD)
Beyond the preview
Go deeper on NCT00064337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00064337.